Antitumor activity of MLN4924, a novel small molecule inhibitor of Nedd8-activating enzyme, in pre-clinical models of lymphoma

被引：0

作者：

Smith, Peter G. ^{[1
]}

Milhollen, Michael ^{[1
]}

Traore, Tary ^{[1
]}

Zhang, Julie ^{[1
]}

Berger, Allison ^{[1
]}

Yu, Jie ^{[1
]}

Garnsey, James ^{[1
]}

Langston, Steve ^{[1
]}

Soucy, Teresa ^{[1
]}

机构：

[1] Millennium Pharmaceut Inc, Cambridge, MA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3602S / 3602S

页数：1

共 50 条

[21] The novel, investigational Nedd8-activating enzyme inhibitor MLN4924 in patients with metastatic melanoma: a phase 1 study
Hamid, O.
Dezube, B. J.
Pickard, M. D.
Shultz, M. A.
Bhatia, S.
EJC SUPPLEMENTS, 2010, 8 (07): : 130 - 130
[22] ACTIVITY OF MLN4924, A NOVEL FIRST IN CLASS SMALL MOLECULE INHIBITOR OF THE NEDD8 ACTIVATING ENZYME, IN PRECLINICAL MODELS OF ACUTE MYELOID LEUKEMIA
Swords, T.
Kelly, K.
Smith, P.
Mahalingam, D.
O'Dwyer, M.
Nawrocki, S.
Giles, F.
Carew, J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 305 - 306
[23] Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
Wei, Dongping
Li, Hua
Yu, Jie
Sebolt, Jonathan T.
Zhao, Lili
Lawrence, Theodore S.
Smith, Peter G.
Morgan, Meredith A.
Sun, Yi
CANCER RESEARCH, 2012, 72 (01) : 282 - 293
[24] Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells
Wang, Yanchun
Luo, Zhongguang
Pan, Yongfu
Wang, Weige
Zhou, Xiaoyan
Jeong, Lak Shin
Chu, Yiwei
Liu, Jie
Jia, Lijun
CANCER BIOLOGY & THERAPY, 2015, 16 (03) : 420 - 429
[25] Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program
Smith, Malcolm A.
Maris, John M.
Gorlick, Richard
Kolb, E. Anders
Lock, Richard
Carol, Hernan
Keir, Stephen T.
Reynolds, C. Patrick
Kang, Min H.
Morton, Christopher L.
Wu, Jianrong
Smith, Peter G.
Yu, Jie
Houghton, Peter J.
PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 246 - 253
[26] Quantifiable analysis of cellular pathway inhibition of a Nedd8-activating enzyme inhibitor, MLN4924, using AlphaScreen
Yan, Zhong-Hua
Burkhardt, Anne
Loke, Huay-Keng
Chen, Jesse
Xu, Qing
Brauer, Pam
Ma, Jingya
Lin, Yafang
Garcia, Khris
Dick, Lawrence R.
Bembenek, Michael E.
ANALYTICAL BIOCHEMISTRY, 2013, 439 (02) : 109 - 115
[27] Pediatric Preclinical Testing Program (PPTP) evaluation of the NEDD8-activating enzyme (NAE) inhibitor MLN4924
Carol, Hernan
Lock, Richard B.
Maris, John M.
Keir, Stephen T.
Gorlick, Richard
Kolb, E. Anders
Kang, Min H.
Reynolds, C. Patrick
Morton, Christopher L.
Smith, Peter G.
Thomas, Michael
McDonald, Alice
Houghton, Peter J.
Smith, Malcolm A.
CANCER RESEARCH, 2011, 71
[28] Stereoselective Synthesis of MLN4924, an Inhibitor of NEDD8-Activating Enzyme (vol 76, pg 3557, 2011)
Lee, Hyuk Woo
Nam, Soo Kyung
Choi, Won Jun
Kim, Hea Ok
Jeong, Lak Shin
JOURNAL OF ORGANIC CHEMISTRY, 2011, 76 (09): : 3614 - 3614
[29] MLN4924, a First-in-Class NEDD8-Activating Enzyme Inhibitor, Attenuates IFN-β Production
Song, Hui
Huai, Wanwan
Yu, Zhongxia
Wang, Wenwen
Zhao, Jing
Zhang, Lining
Zhao, Wei
JOURNAL OF IMMUNOLOGY, 2016, 196 (07): : 3117 - 3123
[30] Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924
Milhollen, Michael A.
Thomas, Michael P.
Narayanan, Usha
Traore, Tary
Riceberg, Jessica
Amidon, Benjamin S.
Bence, Neil F.
Bolen, Joseph B.
Brownell, James
Dick, Lawrence R.
Loke, Huay-Keng
McDonald, Alice A.
Ma, Jingya
Manfredi, Mark G.
Sells, Todd B.
Sintchak, Mike D.
Yang, Xiaofeng
Xu, Qing
Koenig, Erik M.
Gavin, James M.
Smith, Peter G.
CANCER CELL, 2012, 21 (03) : 388 - 401

← 1 2 3 4 5 →